Lifecore Biomedical, Inc. LFCR Reportable Segment — Stock-Based Comp
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s reportable segment — stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s reportable segment — stock-based comp?
- Lifecore Biomedical, Inc. (LFCR) reported reportable segment — stock-based comp of $1.7M in Q1 2026.
- What does reportable segment — stock-based comp mean?
- This metric quantifies the non-cash expense recognized for equity-based awards granted to employees and management within the segment. It is an important measure for understanding the total cost of talent and the potential dilution impact on shareholders.